Concepedia

Robert Doubleday

RD

3

Publications

261

Citations

3

H-Index

1997

Active since

Robert Doubleday is an author specializing in drug discovery, medicinal chemistry, and medicine.

Top concepts

Publications per year

1997–1999

3

Publications

3

Synthesis, Structure−Activity Relationships, and in Vivo Evaluations of Substituted Di-<i>tert</i>-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 1. Thiazolone and Oxazolone Series

Yuntao Song, David T. Connor, Robert Doubleday et al. · Journal of Medicinal Chemistry · 1999 · 130 citations · Full text

, , +20

Synthesis, Structure−Activity Relationships, and in Vivo Evaluations of Substituted Di-<i>tert</i>-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 2. 1,3,4- and 1,2,4-Thiadiazole Series

Yuntao Song, David T. Connor, Anthony D. Sercel et al. · Journal of Medicinal Chemistry · 1999 · 119 citations

, , +23

(Aryloxy)alkylamines as Selective Human Dopamine D<sub>4</sub> Receptor Antagonists:  Potential Antipsychotic Agents

Paul C. Unangst, Thomas Capiris, David T. Connor et al. · Journal of Medicinal Chemistry · 1997 · 12 citations · Full text

, , +19

Rows per page

1–3 of 3